[go: up one dir, main page]

BRPI1009200A2 - derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda - Google Patents

derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda

Info

Publication number
BRPI1009200A2
BRPI1009200A2 BRPI1009200A BRPI1009200A BRPI1009200A2 BR PI1009200 A2 BRPI1009200 A2 BR PI1009200A2 BR PI1009200 A BRPI1009200 A BR PI1009200A BR PI1009200 A BRPI1009200 A BR PI1009200A BR PI1009200 A2 BRPI1009200 A2 BR PI1009200A2
Authority
BR
Brazil
Prior art keywords
thiadiazepines
ampa
benzo
derivatives
nmda receptor
Prior art date
Application number
BRPI1009200A
Other languages
English (en)
Inventor
Cordi Alexis
Danober Laurence
Desos Patrice
Lestage Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI1009200A2 publication Critical patent/BRPI1009200A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36Seven-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI1009200A 2009-03-20 2010-03-18 derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda BRPI1009200A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901300A FR2943342B1 (fr) 2009-03-20 2009-03-20 Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR2010/000227 WO2010106249A1 (fr) 2009-03-20 2010-03-18 Derives de benzothiadiazepines en tant que modulateures des recepteurs ampa et nmda

Publications (1)

Publication Number Publication Date
BRPI1009200A2 true BRPI1009200A2 (pt) 2017-06-13

Family

ID=40863576

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009200A BRPI1009200A2 (pt) 2009-03-20 2010-03-18 derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda

Country Status (44)

Country Link
US (1) US8236790B2 (pt)
EP (1) EP2246339B1 (pt)
JP (1) JP5437473B2 (pt)
KR (1) KR101431504B1 (pt)
CN (1) CN102361860B (pt)
AP (1) AP3050A (pt)
AR (1) AR075892A1 (pt)
AT (1) ATE513822T1 (pt)
AU (1) AU2010200815B2 (pt)
BR (1) BRPI1009200A2 (pt)
CA (1) CA2696705C (pt)
CL (1) CL2011002287A1 (pt)
CO (1) CO6361956A2 (pt)
CR (1) CR20110484A (pt)
CU (1) CU24030B1 (pt)
CY (1) CY1111807T1 (pt)
DK (1) DK2246339T3 (pt)
EA (1) EA020259B1 (pt)
EC (1) ECSP11011340A (pt)
ES (1) ES2368691T3 (pt)
FR (1) FR2943342B1 (pt)
GE (1) GEP20135862B (pt)
HN (1) HN2011002458A (pt)
HR (1) HRP20110626T1 (pt)
IL (1) IL215016A (pt)
JO (1) JO2780B1 (pt)
MA (1) MA33131B1 (pt)
MX (1) MX2011009638A (pt)
MY (1) MY154001A (pt)
NI (1) NI201100169A (pt)
NZ (1) NZ595082A (pt)
PE (1) PE20120113A1 (pt)
PL (1) PL2246339T3 (pt)
PT (1) PT2246339E (pt)
RS (1) RS51919B (pt)
SA (1) SA110310217B1 (pt)
SG (1) SG174274A1 (pt)
SI (1) SI2246339T1 (pt)
TN (1) TN2011000469A1 (pt)
TW (1) TWI388326B (pt)
UA (1) UA100477C2 (pt)
UY (1) UY32475A (pt)
WO (1) WO2010106249A1 (pt)
ZA (1) ZA201001905B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025824B1 (ru) * 2009-07-27 2017-02-28 Джилид Сайэнс, Инк. Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
ES2529119T3 (es) 2010-07-02 2015-02-17 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de canales iónicos
CN103180326B (zh) 2010-08-10 2015-06-10 武田药品工业株式会社 杂环化合物及其用途
AU2011326871B2 (en) 2010-11-04 2015-02-12 Albireo Ab IBAT inhibitors for the treatment of liver diseases
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
AU2015224425B2 (en) * 2011-07-01 2017-02-09 Gilead Sciences, Inc. Fused benzoxazepinones as ion channel modulators
NO3175985T3 (pt) 2011-07-01 2018-04-28
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
JP6134654B2 (ja) 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
DK3921028T3 (da) 2019-02-06 2023-01-23 Albireo Ab Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer
JOP20220063A1 (ar) 2019-09-16 2023-01-30 Takeda Pharmaceuticals Co مشتقات بيريدازين-3(2h)-أون ملتحمة بأزول
JP7695242B2 (ja) 2019-12-04 2025-06-18 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CN111518055A (zh) * 2020-05-16 2020-08-11 西安都创医药科技有限公司 一种苯并硫氮杂卓氧化物的制备方法及其制备的产品及其应用
CN111548325A (zh) * 2020-05-16 2020-08-18 西安都创医药科技有限公司 一种卤代苯并硫氮杂卓化合物的制备方法及其制备的产品及其应用
CN111620838A (zh) * 2020-05-16 2020-09-04 西安都创医药科技有限公司 一种氯代苯并硫氮杂卓化合物的制备方法及其制备的产品及其应用
CN111574475B (zh) * 2020-06-03 2022-09-20 西安都创医药科技有限公司 卤代苯并硫杂卓氧化物的制备方法及其制备的产品及其应用
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
KR20230117393A (ko) 2020-12-04 2023-08-08 알비레오 에이비 벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의용도
CN115368363B (zh) * 2021-05-17 2024-02-20 中山大学 一种手性或消旋的嘧啶并二氮杂环庚酮类化合物及其制备方法和应用
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
TW202500157A (zh) * 2023-05-25 2025-01-01 大陸商正大天晴藥業集團股份有限公司 一種苯並噻二氮卓化合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT70955A (en) * 1992-04-15 1995-11-28 Rhone Poulenc Rorer Sa 3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
EP1054877A1 (en) * 1998-02-11 2000-11-29 Du Pont Pharmaceuticals Company Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
US6156746A (en) * 1998-08-25 2000-12-05 Bristol-Myers Squibb Company 1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents
GB0209467D0 (en) * 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
DE10300973A1 (de) * 2003-01-14 2004-07-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2877338B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2368691T3 (es) 2011-11-21
UA100477C2 (uk) 2012-12-25
HK1167404A1 (en) 2012-11-30
CO6361956A2 (es) 2012-01-20
EP2246339A1 (fr) 2010-11-03
RS51919B (sr) 2012-02-29
SG174274A1 (en) 2011-10-28
EA201101334A1 (ru) 2012-04-30
GEP20135862B (en) 2013-06-25
US20100240635A1 (en) 2010-09-23
PT2246339E (pt) 2011-08-01
AU2010200815A1 (en) 2010-10-07
ZA201001905B (en) 2010-11-24
AP3050A (en) 2014-11-30
MY154001A (en) 2015-04-30
AU2010200815B2 (en) 2015-05-07
TW201036615A (en) 2010-10-16
SA110310217B1 (ar) 2013-06-15
PL2246339T3 (pl) 2011-11-30
NI201100169A (es) 2012-01-11
NZ595082A (en) 2013-12-20
UY32475A (es) 2010-09-30
ATE513822T1 (de) 2011-07-15
AR075892A1 (es) 2011-05-04
KR101431504B1 (ko) 2014-08-20
KR20110128209A (ko) 2011-11-28
HRP20110626T1 (hr) 2011-10-31
JP5437473B2 (ja) 2014-03-12
MA33131B1 (fr) 2012-03-01
CN102361860B (zh) 2014-09-10
FR2943342A1 (fr) 2010-09-24
JO2780B1 (en) 2014-03-15
SI2246339T1 (sl) 2011-09-30
TN2011000469A1 (fr) 2013-03-27
MX2011009638A (es) 2011-09-28
CN102361860A (zh) 2012-02-22
TWI388326B (zh) 2013-03-11
CA2696705A1 (fr) 2010-09-20
DK2246339T3 (da) 2011-10-10
FR2943342B1 (fr) 2011-03-04
ECSP11011340A (es) 2011-10-31
CR20110484A (es) 2011-10-24
CU24030B1 (es) 2014-10-02
JP2012520858A (ja) 2012-09-10
IL215016A0 (en) 2011-11-30
CY1111807T1 (el) 2015-10-07
HN2011002458A (es) 2014-05-19
CU20110169A7 (es) 2012-02-15
EP2246339B1 (fr) 2011-06-22
IL215016A (en) 2013-08-29
EA020259B1 (ru) 2014-09-30
WO2010106249A1 (fr) 2010-09-23
CL2011002287A1 (es) 2012-02-03
PE20120113A1 (es) 2012-02-24
AP2011005935A0 (en) 2011-10-31
CA2696705C (fr) 2013-02-12
US8236790B2 (en) 2012-08-07

Similar Documents

Publication Publication Date Title
BRPI1009200A2 (pt) derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda
BRPI1012770A2 (pt) derivados de tiofeno
BR112013015260A2 (pt) derivados de enxofre como moduladores de receptor de quimiocina
BRPI0918985A2 (pt) derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI0810462A2 (pt) Derivados de quinolina-carboxamida como antagonistas de p2y12
BRPI0809930A2 (pt) Derivados de carboxamida imidazolidina como moduladores de p2x7
BR112012003870A2 (pt) derivados de sulfeto substituídos com 3-triazolilfenila como acaricidas e inseticidas
BRPI1008749A2 (pt) Derivados de benzodiazepina
BRPI0913117A2 (pt) imidazopiridina e análogos relacionados como moduladores de sirtuína
BR112012015868A2 (pt) derivados de imidazolidinadiona
BRPI1006128A2 (pt) derivados de sulfonamida
BR112012010640A2 (pt) novos moduladores de quinase
CU24152B1 (es) 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
BRPI1011477A2 (pt) quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
BRPI1013844A2 (pt) derivados de piridina-isoxazol
BR112012008159A2 (pt) moduladores de receptor canabinoide
BR112012008108A2 (pt) derivados de xantina substituídos
CU23870B1 (es) Derivados de ciclopropilamida como moduladores h3
BRPI0822058A2 (pt) Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7
BR112012010519A2 (pt) derivados de sulfonamida heterocíclicos
BR112013023914A2 (pt) derivados de benzo [b] [1,4] oxazina como moduladores de receptor sensor de cálcio
DK2297100T3 (da) Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer
BRPI1014077A2 (pt) Derivados de tiazolilperidina como fungicidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]